Type I IFN is siloed in endosomes

Autor(en): Altman, Jennie B.
Taft, Justin
Wedeking, Tim
Gruber, Conor N.
Holtmannspoetter, Michael
Piehler, Jacob 
Bogunovic, Dusan
Stichwörter: cytokine retention; endosome; INTERFERONS; Multidisciplinary Sciences; Science & Technology - Other Topics; type I interferon
Erscheinungsdatum: 2020
Herausgeber: NATL ACAD SCIENCES
Journal: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volumen: 117
Ausgabe: 30
Startseite: 17510
Seitenende: 17512
Zusammenfassung: 
Type I IFN (IFN-I) is thought to be rapidly internalized and degraded following binding to its receptor and initiation of signaling. However, many studies report the persistent effects mediated by IFN-I for days or even weeks, both ex vivo and in vivo. These long-lasting effects are attributed to downstream signaling molecules or induced effectors having a long half-life, particularly in specific cell types. Here, we describe a mechanism explaining the long-term effects of IFN-I. Following receptor binding, IFN-I is siloed into endosomal compartments. These intracellular ``IFN silos'' persist for days and can be visualized by fluorescence and electron microscopy. However, they are largely dormant functionally, due to IFN-I-induced negative regulators. By contrast, in individuals lacking these negative regulators, such as ISG15 or USP18, this siloed IFN-I can continue to signal from within the endosome. This mechanism may underlie the long-term effects of IFN-I therapy and may contribute to the pathophysiology of type I interferonopathies.
ISSN: 00278424
DOI: 10.1073/pnas.1921324117

Show full item record

Page view(s)

3
Last Week
0
Last month
1
checked on Feb 22, 2024

Google ScholarTM

Check

Altmetric